Fund Holdings — Sanofi

Total Portfolio Value
$310.41M
Total Bought
$16.02M
Total Sold
$14.60M
Net Transaction
+$1.42M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Inhibrx Biosciences, Inc.(INBX)1,157,9261,157,926038,99991,47629.47%+52,477
MapLight Therapeutics Inc.(MPLT)0912,041+912,041016,0205.16%+16,020
AnaptysBio821,917821,917025,16739,84712.84%+14,679
Q32 Bio Inc.(FIXX)244,083244,08304838100.26%+327
Eledon(ELDN)814,980814,98002,1111,2310.40%-880
Immuneering Corp2,708,5592,708,559018,96017,8225.74%-1,138
LAVA Therapeutics N.V.1,919,4550-1,919,4552,9940—-2,994
MeiraGTx Holdings plc(MGTX)12,197,73712,197,7370100,38796,97231.24%-3,415
Omada Health Inc.(OMDA)524,9030-524,90311,6060—-11,606
Novavax(NVAX)6,880,4816,880,481059,65446,23714.90%-13,417
Page 1 of 1